heart failure
Peters AE, Solomon N, Chiswell K, Fonarow GC, Khouri M, Baylor L, Alvir J, Bruno M, Huda A, Allen LA, Sharma K, DeVore AD, Greene[...]
Chella Krishnan K, El Hachem EJ, Keller M, Patel SG, Carroll L, Vegas AD, Gerdes Gyuricza I, Light C, Cao Y, Pan C, Kaczor-Urbanowicz KE,[...]
Fonarow GC, Greene SJ. Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: Strong Impact Across Ejection Fraction Spectrum. J Am Coll Cardiol. 2023 Jun 6;81(22):2145-2148.[...]
Fudim M, Yazdi D, Egolum U, Haghighat A, Kottam A, Sauer AJ, Shah H, Kumar P, Rakita V, Centen C, Ozonat K, Smith S, DeVore[...]
Kimchi A, Aronow HU, Ni YM, Ong MK, Mirocha J, Black JT, Auerbach AD, Ganiats TG, Greenfield S, Romano PS, Kedan I; BEAT-HF Research Group.[...]
van Weperen VYH, Ripplinger CM, Vaseghi M. Autonomic control of ventricular function in health and disease: current state of the art. Clin Auton Res. 2023[...]
Harrington J, Sun JL, Fonarow GC, Heitner SB, Divanji PH, Binder G, Allen LA, Alhanti B, Yancy CW, Albert NM, DeVore AD, Felker GM, Greene[...]
Brownell NK, Ziaeian B, Fonarow GC. Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction. JACC Asia. 2022 Apr 19;2(2):154-156. doi: 10.1016/j.jacasi.2022.03.002. PMID: 36339123;[...]
Verma A, Heidenreich PA, Ziaeian B. Opportunities for Change in Home Health Care in Heart Failure. JACC Heart Fail. 2023 Mar 31:S2213-1779(23)00135-X. doi: 10.1016/j.jchf.2023.02.018. Epub ahead[...]
Rastogi A, Januzzi JL Jr. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12;12(8):2824. doi:[...]